High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma

Annals of Oncology

Volumn 9, Issue SUPPL. 1, 1998, Pages

  Haioun, C ^a   Lepage, E ^a   Gisselbrecht, C ^a   Coiffier, B ^a   Doyen, C ^a   Morel, P ^a   Attal, M ^a   Tilly, H ^a   Deconinck, E ^a   Gaulard, P ^a   Reyes, F ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Aggressive non Hodgkin's lymphoma; Autologous stem cell transplantation; High dose therapy

Indexed keywords

CISPLATIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE;

CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; DOSE RESPONSE; DRUG MEGADOSE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0031919668     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/9.suppl_1.S5     Document Type: Review

References (18)

1. Lister T.A. Crowther D. Sutcliffe S.B. Report of committee convened to discuss the evaluation of staging of patients with Hodgkin’s disease: Cotswolds meeting J Clin Oncol 7 1989 1630 1636
2. Armitage J.O. Weisenburger D.D. Hutchins M. Chemotherapy for diffuse large cell lymphoma – rapidly responding patients have more durable remissions J Clin Oncol 4 1986 160 164
3. Rahmouni A. Tempany C. Jones R. Lymphoma: Monitoring tumor size and signal intensity with MR imaging Radiology 188 1993 445 451
4. Janicek M. Kaplan M. Neuberg D. Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin’s lymphoma treated with high-dose chemotherapy J Clin Oncol 15 1997 1631 1637
5. Kaplan W.D. Jachelson M.S. Herman T.S. Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma J Clin Oncol 8 1990 1966 1970
6. Vose J.M. Bierman P.J. Anderson J.R. Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin’s lymphoma J Clin Oncol 14 1996 2473 2479
7. 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: A prospective pilot study MAGMA 4 1996 213 224
8. 67Gallium scan in mediastinal malignant lymphoma: A prospective pilot study Ann Oncol 5 1994 433 436
9. Zinzani P.L. Zompatori M. Bendandi M. Monitoring bulky mediastinal disease with Gallium-67, CT-scan and magnetic resonance imaging in Hodgkin’s disease and high-grade non-Hodgkin’s lymphoma Leuk Lymph 22 1996 131 135
10. Hacq R. Sawka C.A. Franssen E. Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin’s lymphoma: A literature review J Clin Oncol 12 1994 1074 1084
11. Philip T. Hartmann O. Biron P. High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin’s lymphoma J Clin Oncol 6 1988 1118 1124
12. Gribben J.G. Goldstone A.H. Linch D.C. Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin’s lymphoma who are still responsive to conventional-dose therapy J Clin Oncol 7 1989 1621 1629
13. Colombat P. Gorin N.C. Lemonnier M.P. The role of autologous bone marrow transplantation in 46 patients with NHL J Clin Oncol 8 1990 630 637
14. Gulati S.C. Shank B. Black P. Autologous bone marrow transplantation for patients with poor prognosis lymphoma J Clin Oncol 6 1988 1303 1313
15. Prince H.M. Crump M. Imrie K. Intensive therapy and autotransplant for patients with an incomplete response to frontline therapy for lymphoma Ann Oncol 7 1996 1043 1049
16. Verdonck L.F. Van Putten W.L.J. Hagenbeek A. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin’s lymphoma N Engl J Med 332 1995 1045 1051
17. Martelli M. Vignetti M. Zinzani P.L. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin and cytarabine in aggressive non-Hodgkin’s lymphoma with partial response to front-line chemotherapy: A prospective randomized Italian multicenter study J Clin Oncol 14 1996 534 542
18. Haioun C. Lepage E. Gisselbrecht C. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin’s lymphoma: Updated results of the prospective study LNH87-2 J Clin Oncol 15 1997 1131 1137